Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015

Details for Mechanism ID: 9240
Country/Region: Uganda
Year: 2014
Main Partner: Uganda Prisons Services
Main Partner Program: NA
Organizational Type: Host Country Government Agency
Funding Agency: HHS/CDC
Total Funding: $0 Additional Pipeline Funding: N/A

NOTE: The following is taken from summaries released by PEPFAR on the PEPFAR Data Dashboard. They are incomplete summary paragraphs only and do not contain the full mechanism details. When the full narratives are released, we will update the mechanism pages accordingly.

Uganda Prison Services (UPS) is an agency of GoU handling safe custody and rehabilitation of offenders. It operates in all regions of the country with 10 facilities equivalent to HC III and 1 Hospital at the level of a general district Hospital. UPS has the responsibility to provide health services to inmates, staff and community members. The focus of this mechanism is to improve the health status of prisoners, staff and their families by strengthening the capacity of UPS to provide HIV prevention, care and treatment services.

This mechanism is ending. Activities over the course of this year are: the completion of the national UPS sero-behavioral survey among prisoners and staff; capacity building trainings for health providers in HIV/TB co-management; roll out and improving data quality in the national health management information system and district health information system 2; service provision for HIV testing and counseling (HCT), PMTCT, and care and treatment to HIV positive patients. UPS will also strengthen HIV/TB surveillance and treatment adherence follow up for continuation of care, and support the national M&E framework.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Testing: HIV Testing and Counseling (HVCT) $0
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
C2.1.D By Age: <15 2015 188
C2.1.D By Age: 15+ 2015 2,257
C2.1.D By Age/Sex: <15 Female 2015 100
C2.1.D By Age/Sex: <15 Male 2015 88
C2.1.D By Age/Sex: 15+ Female 2015 1,487
C2.1.D By Age/Sex: 15+ Male 2015 770
C2.1.D By Sex: Female 2015 1,587
C2.1.D By Sex: Male 2015 858
C2.1.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 2,445
C2.1.D Sum of Age disaggregates 2015 2,445
C2.1.D Sum of Age/Sex disaggregates 2015 2,445
C2.1.D Sum of Sex disaggregates 2015 2,445
C2.1.D_NGI By Age: <15 2015 861
C2.1.D_NGI By Age: 15+ 2015 1,585
C2.1.D_NGI By Age/Sex: <15 Female 2015 81
C2.1.D_NGI By Age/Sex: <15 Male 2015 780
C2.1.D_NGI By Age/Sex: 15+ Female 2015 110
C2.1.D_NGI By Age/Sex: 15+ Male 2015 1,475
C2.1.D_NGI By Sex: Female 2015 191
C2.1.D_NGI By Sex: Male 2015 2,255
C2.1.D_NGI Number of HIV-positive individuals receiving a minimum of one clinical service 2015 2,622
C2.1.D_NGI Sum of Age disaggregates 2015 2,446
C2.1.D_NGI Sum of Age/Sex disaggregates 2015 2,446
C2.1.D_NGI Sum of Sex disaggregates 2015 2,446
C2.4.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 2,445
C2.4.D Number of HIV-positive patients who were screened for TB in HIV care or treatment setting 2015 2,201
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 110
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 81
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 1,475
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 780
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 2,446
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 2,625
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2015 2,446
CARE_NEW Aggregated Age/sex: <15 Female 2015 16
CARE_NEW Aggregated Age/sex: <15 Male 2015 17
CARE_NEW Aggregated Age/sex: 15+ Female 2015 240
CARE_NEW Aggregated Age/sex: 15+ Male 2015 121
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 394
CARE_NEW Sum of Aggregated Age/sex disaggregates 2015 394
FN_SITE By site support type: Technical Assistance-only (TA): Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition 2015 8
FN_SITE By site support type: Technical Assistance-only (TA): Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services 2015 9
FN_SITE Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition 2015 9
FN_SITE Sum of Numerator Support Type disaggregates 2015 8
FN_SITE Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services 2015 10
FN_SITE_den Sum of Denominator Support Type disaggregates 2015 9
FN_THER Number of clinically malnourished PLHIV who received therapeutic and/or supplementary food during the reporting period 2015 9
FN_THER Number of PLHIV who were nutritionally assessed and found to be clinically undernourished 2015 10
HTS_TST Age/sex: 10-14 Female 2015 300
HTS_TST Age/sex: 10-14 Female 2015 300
HTS_TST Age/sex: 10-14 Male 2015 245
HTS_TST Age/sex: 10-14 Male 2015 245
HTS_TST Age/sex: 15-19 Female 2015 252
HTS_TST Age/sex: 15-19 Female 2015 711
HTS_TST Age/sex: 15-19 Female 2015 444
HTS_TST Age/sex: 15-19 Male 2015 260
HTS_TST Age/sex: 15-19 Male 2015 260
HTS_TST Age/sex: 20-24 Female 2015 221
HTS_TST Age/sex: 20-24 Female 2015 622
HTS_TST Age/sex: 20-24 Female 2015 389
HTS_TST Age/sex: 20-24 Male 2015 218
HTS_TST Age/sex: 20-24 Male 2015 218
HTS_TST Age/sex: 25-49 Female 2015 578
HTS_TST Age/sex: 25-49 Female 2015 1,628
HTS_TST Age/sex: 25-49 Female 2015 1,018
HTS_TST Age/sex: 25-49 Male 2015 574
HTS_TST Age/sex: 25-49 Male 2015 574
HTS_TST Age/sex: 5-9 Female 2015 397
HTS_TST Age/sex: 5-9 Female 2015 397
HTS_TST Age/sex: 5-9 Male 2015 325
HTS_TST Age/sex: 5-9 Male 2015 325
HTS_TST Age/sex: 50+ Female 2015 21
HTS_TST Age/sex: 50+ Female 2015 21
HTS_TST Age/sex: 50+ Male 2015 21
HTS_TST Age/sex: 50+ Male 2015 21
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 697
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 571
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 1,072
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 1,910
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 1,073
HTS_TST Aggregated Age/sex: <15 Female 2015 697
HTS_TST Aggregated Age/sex: <15 Male 2015 571
HTS_TST Aggregated Age/sex: 15+ Female 2015 2,982
HTS_TST Aggregated Age/sex: 15+ Male 2015 1,073
HTS_TST By Test Result: Negative 2015 3,142
HTS_TST By Test Result: Negative 2015 4,994
HTS_TST By Test Result: Negative 2015 1,852
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 3,413
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 5,322
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 1,910
HTS_TST Sum of Age/Sex disaggregates 2015 3,412
HTS_TST Sum of Age/Sex disaggregates 2015 5,322
HTS_TST Sum of Age/Sex disaggregates 2015 1,851
HTS_TST Sum of Aggregated Age/Sex <15 2015 1,268
HTS_TST Sum of Aggregated Age/Sex <15 2015 1,268
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 2,145
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 4,055
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 1,910
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 3,413
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 5,323
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 1,910
HTS_TST Sum of Test Result disaggregates 2015 3,413
HTS_TST Sum of Test Result disaggregates 2015 5,322
HTS_TST Sum of Test Result disaggregates 2015 1,909
HTS_TST_POS By Test Result: Positive 2015 271
HTS_TST_POS By Test Result: Positive 2015 328
HTS_TST_POS By Test Result: Positive 2015 57
LAB_ACC By site support type: Direct Service Delivery (DSD) 2015 1
LAB_ACC By site support type: Technical Assistance-only (TA) 2015 1
LAB_ACC Number of PEPFAR-supported testing facilities (laboratories) that are recognized by national, regional, or international standards for accreditation or have achieved a minimal acceptable level towards attainment of such accreditation 2015 2
LAB_ACC Sum of Support Type disaggregates 2015 2
LAB_CAP By clinical laboratories 2015 13
LAB_CAP By site support type: Direct Service Delivery (DSD) 2015 13
LAB_CAP Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2015 13
LAB_CAP Sum of Site Support Type disaggregates 2015 13
PMTCT_ARV Life-long ART (including Option B+) 2015 124
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 137
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 124
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 41
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 83
PMTCT_ARV Sum of New and Current disaggregates 2015 124
PMTCT_ARV Sum of Regimen Type disaggregates 2015 124
PMTCT_ARV_NGI Life-long ART (including Option B+) 2015 124
PMTCT_ARV_NGI Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 137
PMTCT_ARV_NGI Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 124
PMTCT_ARV_NGI Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 41
PMTCT_ARV_NGI Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 83
PMTCT_ARV_NGI Sum of New and Current disaggregates 2015 124
PMTCT_ARV_NGI Sum of Regimen disaggregates 2015 124
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2015 110
PMTCT_EID By infants with a positive virologic test result within 12 months of birth 2015 7
PMTCT_EID Number of HIV- positive pregnant women identified during the reporting period (include known HIV-positive women at entry into PMTCT) 2015 137
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2015 110
PMTCT_EID Sum of Infant Age disaggregates 2015 110
PMTCT_STAT By: Known positives at entry 2015 52
PMTCT_STAT By: Number of new positives identified 2015 85
PMTCT_STAT Number of new ANC and L&D clients 2015 2,065
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 1,962
PMTCT_STAT Sum of Positives Status disaggregates 2015 137
PMTCT_STAT_NGI By: Known positives at entry 2015 52
PMTCT_STAT_NGI By: Number of new positives identified 2015 85
PMTCT_STAT_NGI Number of new ANC and L&D clients 2015 2,065
PMTCT_STAT_NGI Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 1,962
PMTCT_STAT_NGI Sum of Positives Status disaggregates 2015 137
PP_PREV Age/sex: 10-14 Female 2015 120
PP_PREV Age/sex: 10-14 Female 2015 47
PP_PREV Age/sex: 10-14 Male 2015 98
PP_PREV Age/sex: 10-14 Male 2015 35
PP_PREV Age/sex: 15-19 Female 2015 284
PP_PREV Age/sex: 15-19 Female 2015 152
PP_PREV Age/sex: 15-19 Male 2015 104
PP_PREV Age/sex: 15-19 Male 2015 83
PP_PREV Age/sex: 20-24 Female 2015 249
PP_PREV Age/sex: 20-24 Female 2015 133
PP_PREV Age/sex: 20-24 Male 2015 87
PP_PREV Age/sex: 20-24 Male 2015 69
PP_PREV Age/sex: 25-49 Female 2015 651
PP_PREV Age/sex: 25-49 Female 2015 348
PP_PREV Age/sex: 25-49 Male 2015 230
PP_PREV Age/sex: 25-49 Male 2015 183
PP_PREV Age/sex: 50+ Female 2015 9
PP_PREV Age/sex: 50+ Female 2015 14
PP_PREV Age/sex: 50+ Male 2015 9
PP_PREV Age/sex: 50+ Male 2015 7
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2015 1,841
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2015 1,070
PP_PREV Sum of Age/Sex disaggregates 2015 1,841
PP_PREV Sum of Age/Sex disaggregates 2015 1,071
SITE_SUPP By program area/support type: Care and Support Direct Service Delivery (DSD) 2015 10
SITE_SUPP By program area/support type: General Population Prevention Direct Service Delivery (DSD) 2015 10
SITE_SUPP By program area/support type: HTC Direct Service Delivery (DSD) 2015 10
SITE_SUPP By program area/support type: PMTCT Direct Service Delivery (DSD) 2015 10
SITE_SUPP By program area/support type: TB/HIV Direct Service Delivery (DSD) 2015 10
SITE_SUPP By program area/support type: Treatment Direct Service Delivery (DSD) 2015 10
SITE_SUPP By program area/support type: VMMC Direct Service Delivery (DSD) 2015 10
TB_ART Age: 15+ 2015 71
TB_ART Age: 5-14 2015 2
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2015 73
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2015 59
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2015 295
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2015 1,906
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 2,625
TB_SCREEN Sex: Female 2015 1,435
TB_SCREEN Sex: Male 2015 766
TB_SCREEN Sum of Aggregated Age disaggregates 2015 2,201
TB_SCREEN Sum of Sex disaggregates 2015 2,201
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2015 2,201
TX_CURR Aggregated Age/Sex: <15 Female 2015 87
TX_CURR Aggregated Age/Sex: <15 Male 2015 80
TX_CURR Aggregated Age/Sex: 15+ Female 2015 1,330
TX_CURR Aggregated Age/Sex: 15+ Male 2015 673
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2015 2,170
TX_CURR Sum of Aggregated Age/Sex <15 2015 167
TX_CURR Sum of Aggregated Age/Sex 15+ 2015 2,003
TX_CURR Sum of Aggregated Age/Sex disaggregates 2015 2,170
TX_CURR_NGI Aggregated Age/Sex: <15 Female 2015 87
TX_CURR_NGI Aggregated Age/Sex: <15 Male 2015 80
TX_CURR_NGI Aggregated Age/Sex: 15+ Female 2015 1,330
TX_CURR_NGI Aggregated Age/Sex: 15+ Male 2015 673
TX_CURR_NGI Number of adults and children receiving antiretroviral therapy (ART) 2015 2,170
TX_CURR_NGI Sum of Aggregated Age/Sex <15 2015 167
TX_CURR_NGI Sum of Aggregated Age/Sex 15+ 2015 2,003
TX_CURR_NGI Sum of Aggregated Age/Sex disaggregates 2015 2,170
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2015 21
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2015 18
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2015 355
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2015 138
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2015 532
TX_NEW Sum of Aggregated Age/Sex disaggregates 2015 532
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2015 668
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2015 734